2024年ESC关于心房的指导方针:日常临床实践的基本更新
Giuseppe Boriani1, Davide Antonio Mei2,3, Marco Vitolo2
1Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Pozzo 71, 41121, Modena, Italy. giuseppe.boriani@unimore.it.
Internal and emergency medicine
|June 13, 2025
概括
2024年欧洲心脏病学会指南为管理心房 (AF) 提供了关键的更新,包括新的风险得分和扩展的治疗选择. 这些变化旨在改善患者的治疗结果,并简化这种常见的心律障碍的临床实践.
科学领域:
- 心脏病学 心脏病学
- 临床实践指南 临床实践指南
- 心脏节律失常症 心脏节律失常症
背景情况:
- 心房动 (AF) 是最常见的心律失常,导致严重的发病率,死亡率和医疗费用.
- 由于其复杂性和广泛的影响,有效管理AF至关重要.
- 当代医学需要更新的策略,以提供最佳的AF患者护理.
研究的目的:
- 介绍2024年欧洲心脏病学会 (ESC) 对心房 (AF) 管理的指南的关键更新.
- 突出这些新指南对日常临床实践的实际含义.
- 将2024年ESC指南与之前的ESC和美国心脏病学会/美国心脏协会 (ACC/AHA) 的指南进行比较.
主要方法:
- 关于AF管理的2024年ESC指南的审查和综合.
- 确定更新建议的七个关键领域.
- 与之前的ESC (2021) 和ACC/AHA (2023) 准则相比,对2024年ESC准则的比较分析.
主要成果:
- 引入CHA2DS2-VA评分用于血栓塞栓风险分层.
- 修订的出血风险评估策略.
- 扩大了导管切除和左心房附属体关闭的指示.
- 强调AF-CARE途径和心房高发作率的最新管理.
- 在AF的预测分析中考虑人工智能.
结论:
- 2024年ESC指南为治疗心房动的临床医生提供了必要的更新.
- 采用这些基于证据的建议可以优化患者护理和结果.
- 了解区域差异和进展对于全面的AF管理至关重要.
相关概念视频
Disturbances in Heart Rhythm
922
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
922
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
799
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
799
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
Standards of Care II
638
Nurses bear specific legal responsibilities under several federal statutes, including:
638


